Three leading crypto research firms have different views on where Bitcoin will bottom. Galaxy Digital sees a potential drop toward $40,000, NYDIG favors around $50,000, while Standard Chartered ...
Get real-time Corgi Quantum Computing 2x Daily ETF (XQTM) stock price, charts, news, and analyst ratings on Benzinga. Access forecasts, historical data, and expert insights to inform your investment ...
Web site created using create-react-app Kratos Defense & Security (NASDAQ: KTOS) has outperformed the market over the past 10 years by 14.38% on an annualized basis producing an average annual return ...
KIDZ AI stock is climbing Monday after the company pulled the curtain back on KIDZBot, a new robotics learning platform.
Dell Technologies shares are surging Monday after President Donald Trump stood in the Oval Office and told people to buy a ...
On Monday, Microsoft confirmed recent reports that the technology giant is cutting jobs. Microsoft’s Chief People Officer Amy Coleman announced the elimination of 4,800 jobs, or around 2.1% of the ...
Equifax Inc. (NYSE: EFX) shares are consolidating on Monday. They are testing an important resistance level. If the shares can break this resistance, a large move higher may follow. This is why ...
Corgi has continued its aggressive expansion in the ETF market with the launch of 24 new funds on the Cboe BZX Exchange, adding 15 leveraged 2x Daily ETFs and nine July Series Structured Buffer ETFs ...
Gold ETFs are regaining investor attention after cooling inflation expectations, easing oil prices, a weaker dollar and softer U.S. labor market data combined to improve the outlook for the Federal ...
The artificial intelligence race has made semiconductors the stock market’s best-performing industry in 2026, but not every ETF has benefited equally. The gap between the strongest and weakest ...
Bitmine said it has staked 4,879,157 ETH through its institutional staking platform MAVAN, which the company describes as the largest staked ETH position of any entity in the world. At current yields ...
The original bullish thesis centered on Pfizer’s increased R&D focus, a dividend yield of roughly 6%, and management’s goal of delivering high single-digit revenue growth between 2028 and 2032.